Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 3/2003

01-04-2003

The Serum Cytokine Profiles of Lymphoma-associated Hemophagocytic Syndrome: A Comparative Analysis of B-Cell and T-Cell/Natural Killer Cell Lymphomas

Authors: Tatsuharu Ohno, Yasunori Ueda, Ken-ichi Nagai, Takayuki Takahashi, Yoshiteru Konaka, Teruyuki Takamatsu, Takayo Suzuki, Masataka Sasada, Takashi Uchiyama

Published in: International Journal of Hematology | Issue 3/2003

Login to get access
Metadata
Title
The Serum Cytokine Profiles of Lymphoma-associated Hemophagocytic Syndrome: A Comparative Analysis of B-Cell and T-Cell/Natural Killer Cell Lymphomas
Authors
Tatsuharu Ohno
Yasunori Ueda
Ken-ichi Nagai
Takayuki Takahashi
Yoshiteru Konaka
Teruyuki Takamatsu
Takayo Suzuki
Masataka Sasada
Takashi Uchiyama
Publication date
01-04-2003
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 3/2003
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/BF02983788

Other articles of this Issue 3/2003

International Journal of Hematology 3/2003 Go to the issue

Case Report

Cytotoxic T-Cell Lymphoma Arising in Behçet Disease

OriginalPaper

Recent Developments in Hematopoietic Stem Cell Transplantation for Multiple Myeloma

OriginalPaper

In vivo Platelet Activation and Hyperaggregation in Hemoglobin E/β-Thalassemia: A Consequence of Splenectomy

OriginalPaper

Multistep Tumorigenesis of Multiple Myeloma: Its Molecular Delineation

OriginalPaper

Constitutively Activated Rho Guanosine Triphosphatases Regulate the Growth and Morphology of Hairy Cell Leukemia Cells

Letter to the Editor

Pseudoprolongation of the Prothrombin Time During Treatment with Recombinant Factor VIIa for Bleeding in a Patient with a Spontaneous Factor VIII Inhibitor
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits